OBJECTIVE: Pelvic Organ Prolapse (POP) has a multifactorial etiology. We aimed to evaluate the impact of different obstetrical risk factors on later POP development, focusing on pregnancy characteristics, delivery mode, and outcome. STUDY DESIGN: A case control study was performed, comparing different demographic and obstetrical characteristics in women who later developed, or did not develop, pelvic organ prolapse related hospitalizations. POP diagnosis included any hospitalization involving a pre-defined set of ICD-9 POP related codes, as recorded in the hospital computerized records. Deliveries occurred between the years 1991-2017 in a regional tertiary medical center. Study population included women who delivered via vaginal deliveries (VDs) only and those, delivered via cesarean deliveries (CDs) only. A multivariable regression model was constructed to control for confounders. RESULTS: During the study period 106,003 patients met the inclusion criteria; 0.7% (n¼719) of which were later hospitalized with a POP related diagnosis. Of the entire parturient cohort, 86.7% (n¼91,856) delivered via vaginal deliveries only, and 13.3%
OBJECTIVE: Pelvic Organ Prolapse (POP) has a multifactorial etiology. We aimed to evaluate the impact of different obstetrical risk factors on later POP development, focusing on pregnancy characteristics, delivery mode, and outcome. STUDY DESIGN: A case control study was performed, comparing different demographic and obstetrical characteristics in women who later developed, or did not develop, pelvic organ prolapse related hospitalizations. POP diagnosis included any hospitalization involving a pre-defined set of ICD-9 POP related codes, as recorded in the hospital computerized records. Deliveries occurred between the years 1991-2017 in a regional tertiary medical center. Study population included women who delivered via vaginal deliveries (VDs) only and those, delivered via cesarean deliveries (CDs) only. A multivariable regression model was constructed to control for confounders. RESULTS: During the study period 106,003 patients met the inclusion criteria; 0.7% (n¼719) of which were later hospitalized with a POP related diagnosis. Of the entire parturient cohort, 86.7% (n¼91,856) delivered via vaginal deliveries only, and 13.3% (n¼14,147) underwent only CDs. The following parameters were identified as significant risk factors for POP in the univariable analysis: vaginal deliveries, advanced maternal age, multiparity, maternal smoking, hypertensive disorders of pregnancy, maternal diabetes mellitus, macrosomia, and assisted deliveries (Table 1) . Notably, no significant difference was found between the groups in episiotomy rates. However, perineal laceration rate was higher in the POP group.
In the multivariable regression model, controlled for maternal age and ethnicity, the following parameters were found to be independently associated with POP ( compared to non-opioid exposed controls. There is limited data, however, comparing head measurements in neonates with NOWS versus those exposed to opioids who do not develop NOWS. The study objective was to evaluate whether opioid exposure during pregnancy was associated with an increased frequency of abnormal head measurement and whether symptomatic newborns requiring treatment had different head biometry compared to those not requiring treatment. STUDY DESIGN: We performed a retrospective cohort study of pregnant women with a singleton gestation diagnosed with opioid use disorder (OUD) and receiving buprenorphine for medicationassisted treatment (MAT) at a tertiary care academic institution from April 2015 to March 2018. We compared characteristics for newborns treated for NOWS with those not requiring medication. Data collection included head circumference (HC) at birth, demographics, illicit substances, toxicology studies, newborn gender, birth weight, and medical comorbidities. All statistical analyses were performed using SAS 9.4. RESULTS: 173 cases were included in the analysis. The incidence of NOWS was 39.9% (n¼69) in our cohort. There was no statistical significant difference in HC among neonates treated for NOWS (33.4 AE 0.3 cm) and those not treated for NOWS (33.4 AE 0.3 cm). There was no statistical difference in neonatal gender, smoking status, hypertensive disease in pregnancy, or diabetes between the two groups. Of the 173 opioid-exposed neonates, only 15 (8.7%) had a head circumference less than the 10 th percentile. CONCLUSION: Our data found neonates that develop medicationrequiring NOWS do not have a smaller head circumference as compared to opioid-exposed controls. The low incidence for low head circumference does not support the observation these neonates are at marked risk for abnormal brain volumes when enrolled in a comprehensive, multidimensional treatment program. OBJECTIVE: Interpregnancy Interval (IPI) is the time between delivery and subsequent conception. An IPI of 18-24 months is considered ideal and an IPI<18 months has been associated with adverse neonatal outcomes including preterm birth and low birth weight, however data is largely from small cohort studies or non-US populations. We sought to evaluate the association between short IPI and adverse neonatal outcomes in a large, diverse data set. STUDY DESIGN: We conducted a retrospective cohort study using vital statistics birth certificate records between 2012-2015. Women with a singleton, non-anomalous pregnancy and at least one prior live birth were included for analysis. Women were stratified by the IPI as follows: <6 months, 6-11 months, 12 months-18 months, 18-23 months and >¼24 months. Neonatal morbidity was the outcome of
Interpregnancy interval and neonatal outcomes in a large US cohort

